Rebeccamycin, an antitumor antibiotic, inhibits DNA topoisomerase I. Rebeccamycin appears to exert its primary antineoplastic effect by poisoning topoisomerase I and has negligible effect on protein kinase C and topoisomerase. Reference standards of Rebeccamycin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Rebeccamycin [catalogue_number] => PA 18 1760000 [category_ids] => ,78,70,82,170, [chemical_name] => [weight] => 570.38 [form] => C27H21Cl2N3O7 [cas] => 93908-02-2 [pslug] => 93908-02-2-rebeccamycin-pa181760000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 18 1760000
CAS :
Molecular Formula : C27H21Cl2N3O7
Molecular Weight : 570.38
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
